Cytokinetics Inc vs DENTSPLY SIRONA Inc — how do they compare? Cytokinetics Inc trades at $76.67 (market cap $10.63B), while DENTSPLY SIRONA Inc trades at $11.69 (market cap $2.31B). The key difference: Cytokinetics Inc is far larger — about 4.6× DENTSPLY SIRONA Inc's market cap, and DENTSPLY SIRONA Inc pays a 5.04% dividend while Cytokinetics Inc pays none. Which is the better fit depends on your goals.
| CYTK | XRAY | |
|---|---|---|
Market Cap | $10.63B | $2.31B |
Sector | Technology | Health |
52-Week High | $87.26 | $14.68 |
52-Week Low | $34.31 | $9.64 |
Enterprise Value | $10.74B | $4.39B |
Dividend Yield | — | 5.04% |
Trailing returns across standard periods
Cytokinetics is a biopharmaceutical company focused on muscle biology. It develops muscle activators and inhibitors as potential treatments for debilitating diseases where muscle performance is compromised or declining.
Read more on CYTK →Dentsply Sirona Inc is a global manufacturer and distributor of dental supplies and equipment. The company's operating segments include Technologies & Equipment, which is responsible for the design, manufacture, sales, and distribution of products including dental implants, CAD/CAM systems, orthodontic clear aligner products, imaging systems, treatment centers, instruments, as well as certain healthcare device products, primarily catheters
Read more on XRAY →